Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport

[1]  R. Huupponen,et al.  Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study. , 2005, Diabetes.

[2]  Alessandra Bertoldo,et al.  Quantitative assessment of glucose transport in human skeletal muscle: dynamic positron emission tomography imaging of [O-methyl-11C]3-O-methyl-D-glucose. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  P. Perret,et al.  Assessment of insulin sensitivity in vivo in control and diabetic mice with a radioactive tracer of glucose transport: [125I]‐6‐deoxy‐6‐iodo‐D‐glucose , 2003, Diabetes/metabolism research and reviews.

[4]  C. Cobelli,et al.  Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model. , 2003, The Journal of clinical endocrinology and metabolism.

[5]  R. Huupponen,et al.  Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. , 2002, The Journal of clinical endocrinology and metabolism.

[6]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[7]  J. Price,et al.  Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography. , 2001, Diabetes.

[8]  J. Radziuk,et al.  Insulin sensitivity and its measurement: structural commonalities among the methods. , 2000, The Journal of clinical endocrinology and metabolism.

[9]  M. Hays,et al.  A mathematical model for the distribution of fluorodeoxyglucose in humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  K. Ohtomo,et al.  Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  A. Favier,et al.  An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. , 1999, Diabetes.

[12]  C. Morin,et al.  Large-scale synthesis and radiolabelling of 6-deoxy-6-iodo-d-glucose (6-DIG) , 1998 .

[13]  A. Baron,et al.  Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. , 1998, The Journal of clinical investigation.

[14]  C. Ng,et al.  Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  D. Fagret,et al.  [123I]-6-deoxy-6-iodo-D-glucose (6DIG): a potential tracer of glucose transport. , 1997, Nuclear medicine and biology.

[16]  E. Van Obberghen,et al.  Characterization of 6-deoxy-6-iodo-D-glucose: a potential new tool to assess glucose transport. , 1997, Nuclear medicine and biology.

[17]  A. Favier,et al.  Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. , 1997, The Journal of nutrition.

[18]  G. Radda,et al.  Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. , 1996, Journal of Clinical Investigation.

[19]  Simon C Watkins,et al.  The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. , 1996, The Journal of clinical investigation.

[20]  C Cobelli,et al.  Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. , 1996, Diabetes.

[21]  T. Sasaguri,et al.  Cell cycle arrest in the G2 phase induced by phorbol ester and diacylglycerol in vascular endothelial cells. , 1996, The American journal of physiology.

[22]  C. Cobelli,et al.  A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study. , 1996, The American journal of physiology.

[23]  G. Steil,et al.  Assessment of extracellular glucose distribution and glucose transport activity in conscious rats. , 1995, The American journal of physiology.

[24]  A. Favier,et al.  Zinc prevents the structural and functional properties of free radical treated-insulin. , 1994, Biochimica et biophysica acta.

[25]  D. Accili,et al.  Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM? , 1994, Diabetes.

[26]  U. Ruotsalainen,et al.  Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  C. Cobelli,et al.  4 In vivo glucose transport in human skeletal muscle: tools, problems and perspectives , 1993 .

[28]  M. Birnbaum,et al.  1 Cellular insulin action and insulin resistance , 1993 .

[29]  C. Cobelli,et al.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. , 1993, The Journal of clinical investigation.

[30]  W. Burchert,et al.  Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. , 1993, The Journal of clinical investigation.

[31]  C Cobelli,et al.  Glucose Transport in Human Skeletal Muscle: The In Vivo Response to Insulin , 1993, Diabetes.

[32]  Claudio Cobelli,et al.  GLUCOSE-TRANSPORT IN HUMAN SKELETAL-MUSCLE - THE INVIVO RESPONSE TO INSULIN , 1993 .

[33]  M. Birnbaum,et al.  Cellular insulin action and insulin resistance. , 1993, Baillière's Clinical Endocrinology and Metabolism.

[34]  In vivo glucose transport in human skeletal muscle: tools, problems and perspectives. , 1993, Bailliere's clinical endocrinology and metabolism.

[35]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[36]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[37]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[38]  H. Herzog,et al.  Glucose transport and utilization in the human brain: model using carbon-11 methylglucose and positron emission tomography. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  D. James,et al.  Time Dependence of Insulin Action in Muscle and Adipose Tissue in the Rat In Vivo: An Increasing Response in Adipose Tissue with Time , 1985, Diabetes.

[40]  J. Jacquez.  Compartmental analysis in biology and medicine , 1985 .

[41]  Claudio Cobelli,et al.  A model of glucose kinetics and their control by insulin, compartmental and noncompartmental approaches , 1984 .

[42]  M. Larsson,et al.  Effects of isotonic fluid load on plasma water and extracellular fluid volumes in the rat. , 1983, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[43]  J J DiStefano,et al.  Comprehensive kinetics of triiodothyronine production, distribution, and metabolism in blood and tissue pools of the rat using optimized blood-sampling protocols. , 1982, Endocrinology.

[44]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[45]  G. Kloster,et al.  3-[11C]-methyl-D-glucose, a potential agent for regional cerebral glucose utilization studies: Synthesis, chromatography and tissue distribution in mice , 1981 .

[46]  C. Cobelli,et al.  Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.

[47]  A. Wolf,et al.  Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  K. Bellmann,et al.  Jacquez, J. A.: Compartmental analysis. Biology and Medicine. Elsevier Publ. Co., Amsterdam, New York 1972. XIV, 237 S., 93 Abb., 1 Tab., $24.35 , 1974 .

[49]  E. Bessell,et al.  The use of deoxyfluoro-D-glucopyranoses and related compounds in a study of yeast hexokinase specificity. , 1972, The Biochemical journal.

[50]  J. Wilson,et al.  The fate of 3-O-14CH3-glucose in the rat. , 1956, Biochimica et biophysica acta.